Primary hyperparathyroidism

Oncologist

Volumn 12, Issue 6, 2007, Pages 644-653

  Suliburk, James W ^a   Perrier, Nancy D ^b,c  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c NONE   (United States)

Author keywords

Asymptomatic hyperparathyroidism; Hypercalcemia; Parathyroidectomy; Primary hyperparathyroidism

Indexed keywords

ALKALINE PHOSPHATASE; ANALGESIC AGENT; ANTIEMETIC AGENT; CALCITRIOL; CALCIUM; ERGOCALCIFEROL; GABAPENTIN; LEVOTHYROXINE; LITHIUM; MAGNESIUM; METFORMIN; METOPROLOL; NARCOTIC ANALGESIC AGENT; PARATHYROID HORMONE; QUINAPRIL; SIMVASTATIN; TECHNETIUM 99M; THIAZIDE DIURETIC AGENT;

ANAMNESIS; ARTICLE; BONE DENSITY; CALCIUM BLOOD LEVEL; CLINICAL FEATURE; DIAGNOSTIC IMAGING; FOLLOW UP; HUMAN; HYPERCALCEMIA; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPOCALCEMIA; KIDNEY CALCIFICATION; LABORATORY TEST; MATURITY ONSET DIABETES MELLITUS; NAUSEA AND VOMITING; NEUROMUSCULAR DISEASE; OSTEOPOROSIS; PANCREATITIS; PARATHYROID ADENOMA; PARATHYROIDECTOMY; PEPTIC ULCER; PHYSICAL EXAMINATION; POSTOPERATIVE PAIN; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; QUALITY OF LIFE; RECURRENT DISEASE; SECONDARY HYPERPARATHYROIDISM; TREATMENT OUTCOME; VITAMIN D DEFICIENCY;

CALCIUM; FEMALE; HUMANS; HYPERPARATHYROIDISM, PRIMARY; MIDDLE AGED; PARATHYROIDECTOMY; SURGICAL PROCEDURES, MINIMALLY INVASIVE; TREATMENT OUTCOME;

EID: 34447129535     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.12-6-644     Document Type: Article

References (41)

1. Bilezikian JP, Silverberg SJ. Clinical practice. Asymptomatic primary hyperparathyroidism. N Engl J Med 2004;350:1746-1751.
2. Mandl F. Therapeutischer versuch ber ostitis fibrosa generalisata mittels extirpation eine epithelkorpercher-tumors. Wien Klin Wochenschr 1925;38:1343.
3. Bauer W, Albright F, Aub JC. A case of osteitis fibrosa cystica (osteomalacia?) with evidence of hyperactivity of the para-thyroid bodies. Metabolic study II. J Clin Invest 1930;8:229-248.
4. Eigelberger MS, Clark OH. Surgical approaches to primary hyperparathyroidism. Endocrinol Metab Clin North Am 2000;29:479-502.
5. Silverberg SJ, Bilezikian JP, Bone HG et al. Therapeutic controversies in primary hyperparathyroidism. J Clin Endocrinol Metab 1999;84:2275-2285.
6. Pasieka JL, Parsons LL, Demeure MJ et al. Patient-based surgical outcome tool demonstrating alleviation of symptoms following parathyroidectomy in patients with primary hyperparathyroidism. World J Surg 2002;26:942-949.
7. Perrier ND. Asymptomatic hyperparathyroidism: A medical misnomer? Surgery 2005;137:127-131.
8. Solomon BL, Schaaf M, Smallridge RC. Psychologic symptoms before and after parathyroid surgery. Am J Med 1994;96:101-106.
9. Larsson K, Ljunghall S, Krusemo UB et al. The risk of hip fractures in patients with primary hyperparathyroidism: A population-based cohort study with a follow-up of 19 years. J Intern Med 1993;234:585-593.
10. Lundgren E, Lind L, Palmer M et al. Increased cardiovascular mortality and normalized serum calcium in patients with mild hypercalcemia followed up for 25 years. Surgery 2001;130:978-985.
11. Piovesan A, Molineri N, Casasso F et al. Left ventricular hypertrophy in primary hyperparathyroidism. Effects of successful parathyroidectomy. Clin Endocrinol (Oxf) 1999;50:321-328.
12. Silverberg SJ, Locker FG, Bilezikian JP. Vertebral osteopenia: A new indication for surgery in primary hyperparathyroidism. J Clin Endocrinol Metab 1996;81:4007-4012.
13. Vestergaard P, Mollerup CL, Frokjaer VG et al. Cardiovascular events before and after surgery for primary hyperparathyroidism. World J Surg 2003;27:216-222.
14. Roman SA, Sosa JA, Mayes L et al. Parathyroidectomy improves neurocognitive deficits in patients with primary hyperparathyroidism. Surgery 2005;138:1121-1128; discussion 1128-1129.
15. Jacobs TP, Bilezikian JP. Clinical review: Rare causes of hypercalcemia. J Clin Endocrinol Metab 2005;90:6316-6322.
16. Bilezikian JP, Potts JT Jr, Fuleihan Gel-H et al. Summary statement from a workshop on asymptomatic primary hyperparathyroidism: A perspective for the 21st century. J Bone Miner Res 2002;17(suppl 2):N2-N11.
17. Silverberg SJ, Shane E, Jacobs TP et al. A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N Engl J Med 1999;341:1249-1255.
18. Eigelberger MS, Cheah WK, Ituarte PH et al. The NIH criteria for parathyroidectomy in asymptomatic primary hyperparathyroidism: Are they too limited? Ann Surg 2004;239:528-535.
19. Sywak MS, Knowlton ST, Pasieka JL et al. Do the National Institutes of Health consensus guidelines for parathyroidectomy predict symptom severity and surgical outcome in patients with primary hyperparathyroidism? Surgery 2002;132:1013-1019; discussion 1019-1020.
20. AACE/AAES Task Force on Primary Hyperparathyroidism. The American Association of Clinical Endocrinologists and the American Association of Endocrine Surgeons position statement on the diagnosis and management of primary hyperparathyroidism. Endocr Pract 2005;11:49-54.
21. Abdelhadi M, Nordenstrom J. Bone mineral recovery after parathyroidectomy in patients with primary and renal hyperparathyroidism. J Clin Endocrinol Metab 1998;83:3845-3851.
22. Neer RM, Arnaud CD, Zanchetta JR et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 2001;344:1434-1441.
23. Gilat H, Cohen M, Feinmesser R et al. Minimally invasive procedure for resection of a parathyroid adenoma: The role of preoperative high-resolution ultrasonography. J Clin Ultrasound 2005;33:283-287.
24. Ishibashi M, Nishida H, Hiromatsu Y et al. Comparison of technetium-99m-MIBI, technetium-99m-tetrofosmin, ultrasound and MRI for localization of abnormal parathyroid glands. J Nucl Med 1998;39:320-324.
25. Rodgers SE, Hunter GJ, Hamberg LM et al. Improved preoperative planning for directed parathyroidectomy with 4-dimensional computed tomography. Surgery 2006;140:932-940; discussion 940-941.
26. Chen H, Sokoll LJ, Udelsman R. Outpatient minimally invasive parathyroidectomy: A combination of sestamibi-SPECT localization, cervical block anesthesia, and intraoperative parathyroid hormone assay. Surgery 1999;126:1016-1021; discussion 1021-1022.
27. Kouvaraki MA, Greer M, Sharma S et al. Indications for operative intervention in patients with asymptomatic primary hyperparathyroidism: Practice patterns of endocrine surgery. Surgery 2006;139:527-534.
28. Miccoli P, Bendinelli C, Conte M et al. Endoscopic parathyroidectomy by a gasless approach. J Laparoendosc Adv Surg Tech A 1998;8:189-194.
29. Miccoli P, Bendinelli C, Vignali E et al. Endoscopic parathyroidectomy: Report of an initial experience. Surgery 1998;124:1077-1079; discussion 1079-1080.
30. Henry JF, Iacobone M, Mirallie E et al. Indications and results of video-assisted parathyroidectomy by a lateral approach in patients with primary hyperparathyroidism. Surgery 2001;130:999-1004.
31. Henry JF, Raffaelli M, Iacobone M et al. Video-assisted parathyroidectomy via the lateral approach vs conventional surgery in the treatment of sporadic primary hyperparathyroidism: Results of a case-control study. Surg Endosc 2001;15:1116-1119.
32. Ikeda Y, Takami H, Sasaki Y et al. Endoscopic neck surgery by the axillary approach. J Am Coll Surg 2000;191:336-340.
33. Westerdahl J, Lindblom P, Valdemarsson S et al. Risk factors for postoperative hypocalcemia after surgery for primary hyperparathyroidism. Arch Surg 2000;135:142-147.
34. Westerdahl J, Valdemarsson S, Lindblom P et al. Postoperative elevated serum levels of intact parathyroid hormone after surgery for parathyroid adenoma: Sign of bone remineralization and decreased calcium absorption. World J Surg 2000;24:1323-1329.
35. Caron NR, Sturgeon C, Clark OH. Persistent and recurrent hyperparathyroidism. Curr Treat Options Oncol 2004;5:335-345.
36. Mariette C, Pellissier L, Combemale F et al. Reoperation for persistent or recurrent primary hyperparathyroidism. Langenbecks Arch Surg 1998;383:174-179.
37. Jones JJ, Brunaud L, Dowd CF et al. Accuracy of selective venous sampling for intact parathyroid hormone in difficult patients with recurrent or persistent hyperparathyroidism. Surgery 2002;132:944-950; discussion 950-941.
38. Mundschenk J, Klose S, Lorenz K et al. Diagnostic strategies and surgical procedures in persistent or recurrent primary hyperparathyroidism. Exp Clin Endocrinol Diabetes 1999;107:331-336.
39. Shoback DM, Bilezikian JP, Turner SA et al. The calcimimetic cinacalcet normalizes serum calcium in subjects with primary hyperparathyroidism. J Clin Endocrinol Metab 2003;88:5644-5649.
40. Strewler GJ. Medical approaches to primary hyperparathyroidism. Endocrinol Metab Clin North Am 2000;29:523-539, vi.
41. Edwards ME, Rotramel A, Beyer T et al. Improvement in the health-related quality-of-life symptoms of hyperparathyroidism is durable on long-term follow-up. Surgery 2006;140:655-664.